221 related articles for article (PubMed ID: 31183306)
1. Systemic Sclerosis and Systemic Lupus Erythematosus Overlap Syndrome with Pulmonary Arterial Hypertension Successfully Treated with Immunosuppressive Therapy and Riociguat.
Kuzuya K; Tsuji S; Matsushita M; Ohshima S; Saeki Y
Cureus; 2019 Mar; 11(3):e4327. PubMed ID: 31183306
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary hypertension on systemic sclerosis-lupus erythematosus overlap syndrome.
Rachdi I; Tougorti M; Daoud F; Aydi Z; Zoubeidi H; Ben Dhaou B; Boussema F
Ann Cardiol Angeiol (Paris); 2019 Oct; 68(4):221-225. PubMed ID: 30685083
[TBL] [Abstract][Full Text] [Related]
3. Replacing a phosphodiesterase-5 inhibitor with riociguat in patients with connective tissue disease-associated pulmonary arterial hypertension: a case series.
Raina A; Benza RL; Farber HW
Pulm Circ; 2017; 7(3):741-746. PubMed ID: 28671485
[TBL] [Abstract][Full Text] [Related]
4. Determining the necessity for right heart catheterization in pulmonary hypertension associated with connective tissue diseases assessed by echocardiography.
Choi JH; Joo SJ; Kim J
Int J Rheum Dis; 2016 Jan; 19(1):65-73. PubMed ID: 26820839
[TBL] [Abstract][Full Text] [Related]
5. Severe pulmonary arterial hypertension and interstitial pneumonia related to systemic lupus erythematosus successfully treated with mycophenolate mofetil: A novel case report.
Nawata M; Nagayasu A; Fujita Y; Nawata A; Saito K; Tanaka Y
Lupus; 2020 Dec; 29(14):1955-1960. PubMed ID: 32914681
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and Survival of Systemic Sclerosis-Systemic Lupus Erythematosus Overlap Syndrome.
Alharbi S; Ahmad Z; Bookman AA; Touma Z; Sanchez-Guerrero J; Mitsakakis N; Johnson SR
J Rheumatol; 2018 Oct; 45(10):1406-1410. PubMed ID: 30008448
[TBL] [Abstract][Full Text] [Related]
7. [Pulmonary arterial hypertension associated with connective tissue diseases].
Legendre P; Mouthon L
Presse Med; 2014 Sep; 43(9):957-69. PubMed ID: 25129118
[TBL] [Abstract][Full Text] [Related]
8. Successful transition from intravenous epoprostenol to oral selexipag and inhaled iloprost in a case of severe pulmonary arterial hypertension associated with systemic lupus erythematosus.
Saiki C; Kashiwado Y; Yokoyama T; Ayano M; Imabayashi K; Kawano S; Higashioka K; Kimoto Y; Fukata M; Mitoma H; Ono N; Arinobu Y; Akashi K; Horiuchi T; Niiro H
Mod Rheumatol Case Rep; 2022 Jun; 6(2):183-188. PubMed ID: 35134204
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases.
Jais X; Launay D; Yaici A; Le Pavec J; Tchérakian C; Sitbon O; Simonneau G; Humbert M
Arthritis Rheum; 2008 Feb; 58(2):521-31. PubMed ID: 18240255
[TBL] [Abstract][Full Text] [Related]
10. Perinatal Management and Long-Term Follow-up of a Primipara With Severe Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus.
Song W; Chu S; Yang K; Sun X; Xia H; Mei C; Zhao Y; Wu J
J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt A):2511-2517. PubMed ID: 34247927
[TBL] [Abstract][Full Text] [Related]
11. Successful bosentan therapy in a case of pulmonary arterial hypertention developed during immunosuppressive therapy for lupus nephritis.
Ueda Y; Takahashi Y; Yamashita H; Kaneko H; Mimori A
Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(2):99-104. PubMed ID: 21628852
[TBL] [Abstract][Full Text] [Related]
12. [A case of mixed connective tissue disease developed into overlap syndrome of progressive systemic sclerosis, systemic lupus erythematosus, polymyositis and Sjögren's syndrome].
Akiyama Y; Suzuki T; Tanaka M; Kobayashi K; Kagiri T; Ishibashi T; Kitagawa H; Imai F; Hara K; Doi Y
Arerugi; 1990 Jun; 39(6):542-7. PubMed ID: 2222196
[TBL] [Abstract][Full Text] [Related]
13. [Pulmonary arterial hypertension related to connective tissue diseases].
Pehlivan O; Inanç M
Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():57-62. PubMed ID: 20819768
[TBL] [Abstract][Full Text] [Related]
14. Pulse dose steroids in severe pulmonary arterial hypertension secondary to systemic lupus erythematosus.
Lee C; Elwing J
SAGE Open Med Case Rep; 2017; 5():2050313X17707153. PubMed ID: 28515936
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary arterial hypertension in the setting of scleroderma is different than in the setting of lupus: A review.
Bazan IS; Mensah KA; Rudkovskaia AA; Adonteng-Boateng PK; Herzog EL; Buckley L; Fares WH
Respir Med; 2018 Jan; 134():42-46. PubMed ID: 29413506
[TBL] [Abstract][Full Text] [Related]
16. Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study).
Marra AM; Halank M; Benjamin N; Bossone E; Cittadini A; Eichstaedt CA; Egenlauf B; Harutyunova S; Fischer C; Gall H; Ghofrani HA; Hoeper MM; Lange TJ; Olsson KM; Klose H; Grünig E
Respir Res; 2018 Dec; 19(1):258. PubMed ID: 30567595
[TBL] [Abstract][Full Text] [Related]
17. Change of right heart size and function by long-term therapy with riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Marra AM; Egenlauf B; Ehlken N; Fischer C; Eichstaedt C; Nagel C; Bossone E; Cittadini A; Halank M; Gall H; Olsson KM; Lange TJ; Grünig E
Int J Cardiol; 2015 Sep; 195():19-26. PubMed ID: 26011408
[TBL] [Abstract][Full Text] [Related]
18. First-in-child use of the oral soluble guanylate cyclase stimulator riociguat in pulmonary arterial hypertension.
Spreemann T; Bertram H; Happel CM; Kozlik-Feldmann R; Hansmann G
Pulm Circ; 2018; 8(1):2045893217743123. PubMed ID: 29099661
[TBL] [Abstract][Full Text] [Related]
19. Successful Treatment of Pulmonary Arterial Hypertension in Systemic Sclerosis with Anticentriole Antibody.
Ishii Y; Fujii H; Sugimura K; Shirai T; Hoshi Y; Fujita Y; Shirota Y; Ishii T; Shimokawa H; Harigae H
Case Rep Rheumatol; 2020; 2020():1926908. PubMed ID: 32158583
[TBL] [Abstract][Full Text] [Related]
20. Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies.
Tselios K; Gladman DD; Urowitz MB
Open Access Rheumatol; 2017; 9():1-9. PubMed ID: 28053559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
